Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nonlytic Egress and Transmission in the Virus World. | Annu Rev Biochem | 2025 | 40540754 | PubTator, text mining | PubMed |
| Single-cell dissection of prognostic architecture and immunotherap response in Helicobacter pylori infection-associated gastric cancer. | Elife | 2025 | 40525824 | PubTator, text mining | PubMed |
| Enhancing Marathon Enthusiast Engagement Through AI: A Quantitative Study on the Role of Social Media in Sports Communication. | Brain Behav | 2025 | 40524656 | PubTator, text mining | PubMed |
| Functional Localization of Visual Motion Area FST in Humans. | Imaging Neurosci (Camb) | 2025 | 40510805 | PubTator, text mining | PubMed |
| Target Engagement Assays in Early Drug Discovery. | J Med Chem | 2025 | 40465835 | PubTator, text mining | PubMed |
| Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential. | Front Immunol | 2025 | 40433363 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy. | Cells | 2025 | 40422244 | PubTator, text mining | PubMed |
| Prospects of current AXL-targeting therapies in early phase cancer trials. | Expert Opin Investig Drugs | 2025 | 40413629 | PubTator, text mining | PubMed |
| Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. | J Immunother Cancer | 2025 | 40379271 | PubTator, text mining | PubMed |
| Integrative multi-omics and Mendelian randomization analysis reveal SPP1+ tumor-associated macrophage-driven prognostic signature for hepatocellular carcinoma. | Front Mol Biosci | 2025 | 40376263 | PubTator, text mining | PubMed |
| The effects of interleukin-21 in the biology of transplant rejection. | Front Immunol | 2025 | 40376002 | PubTator, text mining | PubMed |
| Comprehensive analysis of SQOR involvement in ferroptosis resistance of pancreatic ductal adenocarcinoma in hypoxic environments. | Front Immunol | 2025 | 40375994 | PubTator, text mining | PubMed |
| The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer. | Front Med (Lausanne) | 2025 | 40370720 | PubTator, text mining | PubMed |
| Molecular mechanism of thyroxine transport by monocarboxylate transporters. | Nat Commun | 2025 | 40368961 | PubTator, text mining | PubMed |
| CCL18 derived from M2-polarized tumor-associated macrophages promotes endometrial cancer progression by activating the TWIST1/HMGA1 axis. | Neoplasma | 2025 | 40353623 | PubTator, text mining | PubMed |
| Identification of YAP regulators through high-throughput screening and NanoBiT-based validation-drug repositioning for cancer therapy. | Anim Cells Syst (Seoul) | 2025 | 40353256 | PubTator, text mining | PubMed |
| The role and clinical significance of tumor-associated macrophages in the epithelial-mesenchymal transition of lung cancer. | Front Oncol | 2025 | 40304000 | PubTator, text mining | PubMed |
| Opioid overdose, suicide mortality, and premature death among veterans with alcohol or opioid use disorders: The impact of military sexual trauma. | Addict Behav | 2025 | 40262404 | PubTator, text mining | PubMed |
| A reliable tool for assessment of acceptance of e-consultation service in hospitals: the modified e-consultation Technology Acceptance Model (TAM) questionnaire. | J Egypt Public Health Assoc | 2025 | 40261534 | PubTator, text mining | PubMed |
| Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm. | Exp Ther Med | 2025 | 40242601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=7